▶ Full Post Text
I want to walk through a situation that I think is a genuine value opportunity, not a falling knife. Happy to be challenged on any of this.
Amplitude went public in 2021 at around $87 per share. It now trades below $8. The 91% decline has left it lumped in with every other pandemic-era SaaS name that got swept up in the bubble and never deserved its valuation. That narrative is understandable. It is also about five quarters out of date.
**WHAT THE COMPANY ACTUALLY DOES**
Amplitude runs a digital analytics platform. Product teams at companies across technology, media, finance, and e-commerce use it to understand how users behave inside their products. Which features drive retention, where conversion drops off, and what experiments actually move the needle. It is not a discretionary line item. You can cut headcount, you can defer infrastructure spend, but you cannot ship a product without knowing whether it works. The competitive landscape includes Google Analytics (free but limited), Mixpanel (private, smaller), and Heap (acquired by Contentsquare). Amplitude sits at the enterprise end of the market.
**THE NUMBERS THAT THE MARKET IS NOT PRICING**
Five consecutive quarters of ARR acceleration. ARR growth has moved from mid-single-digit to 17% year-over-year, hitting $366M as of Q4 2025 (reported February 18, 2026). Q4 revenue came in at $91.4M against a consensus estimate of $90.4M. FY2025 revenue was $343.2M, up 15% year-over-year. The company delivered its first quarter of positive non-GAAP operating income and is guiding for GAAP profitability in FY2026 for the first time in its history, with EPS guidance of $0.08 to $0.13.
Remaining performance obligations came in at $391.9M, up 37% year-over-year. Customers paying over $100K annually grew 15% year-over-year to 653. These are not the numbers of a business in decline.
The company also authorized a $100M share buyback. At a market cap of roughly $1.03B and a share price around $7.87, that represents nearly 12% of shares outstanding. Management authorized this alongside a GAAP profitability guide. You do not do that if you think the business is deteriorating.
**THE VALUATION GAP**
At roughly $7.87, Amplitude trades at approximately 2.3x FY2026 revenue guidance (midpoint around $394M). For context, the median SaaS company growing 15 to 20% with positive operating margins currently trades at 5 to 7x forward revenue. The analyst consensus from 12 covering analysts is unanimous Strong Buy, with an average price target in the $13.50 to $15.67 range. Former resistance levels sit around $17 to $18.
The stock would need to roughly double to reach the low end of fair value for a business with this growth profile. That gap exists because institutional investors who got burned on the 2021 valuation are not revisiting the name, and small-cap SaaS as a category remains out of favor with most allocators.
**THE AI PRODUCT LAYER**
In 2025 Amplitude launched AI Agents, MCP integration, and a product called AI Visibility that shows brands how they appear in AI search results. AI agents now drive approximately 25% of platform queries, according to management commentary on the Q4 2025 call. This is not an AI wrapper bolted on for marketing purposes. It makes the platform accessible to non-technical users who previously needed a data analyst to get answers, expanding the addressable user base within each customer and increasing switching costs.
**THE RISKS ARE REAL**
The President of the company, Thomas Hansen, departed on February 24, 2026, effective March 31. The company reaffirmed guidance the same day and promoted the Chief Revenue Officer to a new Chief Commercial Officer role. One executive departure at this stage of a turnaround is not automatically a red flag, but it is worth watching. If there are further departures over the next two to three months, that pattern changes the picture.
Competitive pressure from Google Analytics 4 is structural. Google can bundle more advanced product analytics into a free tier at any point, and if it does, Amplitude's enterprise pricing power erodes. This risk has existed for years and has not materialized in a way that has stopped ARR acceleration, but it is the correct bear case.
The FY2026 profitability guide is thin, $0.08 to $0.13 adjusted EPS. Any margin miss on Q1 2026 earnings (expected May 13) would immediately reactivate the broken SaaS narrative in the market. The stock is also illiquid by large-cap standards, with an average daily volume around 3 million shares, which means drawdowns can be sharp and exits can involve slippage.
**WHY THE NARRATIVE HAS NOT BROKEN YET**
This is probably the most interesting part of the setup. The fundamentals have clearly improved. Twelve analysts covering the name are unanimously bullish. The buyback is authorized. Guidance is for profitability. And yet the stock sits at 2.3x forward revenue as though none of this has happened.
The reason is what I would call category contamination. The 2021 SaaS cohort left institutional memory scarred in a specific way. Portfolio managers who owned these names at 20 to 30x revenue and watched them fall 80 to 90% are not going back. The coverage analyst who downgraded it in 2022 has moved on. The stock is essentially invisible to the people with the capital to re-rate it.
Re-ratings in this situation usually require a catalyst that is impossible to ignore. A clean Q1 earnings beat with raised guidance, active buyback execution showing up in share counts, or a major customer win publicized in a way that cannot be explained away. None of those have happened yet. The question is whether they happen before someone else notices the setup.
The Q1 2026 earnings print on May 13 is the most important near-term event. ARR growth needs to stay above 15%, the $100K+ customer cohort needs to keep growing, and any commentary on buyback execution will matter.
What is your read on the category contamination dynamic here? Does the re-rating require a specific type of catalyst, or is this the kind of situation that just quietly compounds until a larger player takes notice?